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A great number of physiological mechanisms of 
growth control that regulate cell proliferation and 
tissue homeostasis are closely related to apoptosis, 
and, therefore, tumor cell resistance to apoptosis 
represents undoubtedly a distinctive and important 
feature of these cells. At the same time, in each tumor, 
cell population is heterogeneous and contains both 
cells with a disturbеd programme of apoptosis, and 
cells having preserved this programme. The intensity 
of spontaneous apoptosis in tumors depends upon 
their origin, cell type, histological variant, stage of 
tumor progression, and other factors which, being 
in interaction with each other, have an impact on the 
character and intensity of apoptosis.
Data on apoptosis intensity in thyroid tumors are 
rather contradictory: the highest intensity was re-
ported for medullary, anaplastic, and oxyphilic-cell 
carcinomas [1, 2], while in papillary and follicular 
carcinomas apoptosis level appeared to be low [3]. 
On the contrary, morphologic studies have shown 
that the index of apoptosis in papillary carcinomas 
was much higher compared to follicular and medullary 
carcinomas where it was equal to zero [4]. Properly for 
papillary thyroid carcinomas, apoptotic activity was 
shown to vary: in 41% of carcinomas it was at a trace 
level (which is typical of normal tissue), in 44% it was 
low, and in 15% apoptotic activity was high [5].
Apoptosis may be initiated either from without 
(through formation of a ligand-receptor complex), or 
through an internal mitochondrial pathway, in most 
of cases this being accompanied by an activation of 
caspase cascades and caspase translocation from 
one cell compartment to another. The sequence of 
interaction of these enzymes also depends on cell 
type [6]. Among 11 known caspases in humans, a 
special role belongs to effector ones (caspases 3, 6, 7) 
that are responsible for cell substrate cleavage, which 
determines all the range of characteristic biochemical 
and morphological changes in a dying cell [7, 8].
A study of effector caspase activation, includ-
ing caspase-3, in tumoral cells allows to assess the 
pharmacological drug effects aimed at enhancing 
the apoptosis of transformed cells or decreasing the 
threshold of their sensitivity to proapoptotic stimuli [9]. 
Such investigations are also known for thyroid tumors 
[10–12]; however, data on caspase-3 activity in these 
tumors as a marker of spontaneous apoptosis are 
rather limited [13].
The aim of this work was to determine cas-
pase-3 activity in papillary thyroid carcinoma tissue in 
patients and analyze the peculiarities of changes in this 
activity depending on a number of pathomorphological 
and clinical characteristics of tumoral process.
MATERIALS AND METHODS
Patients. We have studied 12 specimens of extra-
tumoral unchanged tissue of normofollicular structure 
and 15 specimens of papillary thyroid carcinoma tissue 
from patients having undergone a surgical treatment 
at the Surgery Department of the Institute of Endocri-
nology and Metabolism. Patients were informed and 
gave their consent to using the tissues removed during 
the operation for research purposes. A permission for 
study performance was obtained from the Committee 
for Biomedical Ethics of the Institute. Among 23 pa-
tients, there were 21 women and 2 men, aged 30.0 
± 3.4 years and 28.6 ± 2.1 years, respectively, in the 
above specimen groups.
Caspase-3 activity and protein concentration 
assays. Preparation of lisates of thyroid and carcinoma 
tissues, and assessment of caspase-3 activity were car-
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ried out with regard to acetyl-asp-glu-val-asp-parani-
troanilide, according to the protocol of the manufacturer 
of reagent kit for spectrophotometry assay of enzyme 
activity (“CASP-3”, Sigma, U.S.A.). Enzyme activity 
was expressed in μmol of paranitroaniline/(hour х mg 
of protein). Protein content was determined using one 
of the Lowry method modifications [14].
The statistical processing of the data obtainеd was 
performed using Student “t” criterium and Wilcoxon  —
Mann — Whitney non-parametric “U” criterium. The 
critical level of significance was assumed to be equal 
to 0.05. In the Tables data are presented as M ± m.
RESULTS
Our studies have shown that in papillary carcinoma 
tissue the average caspase-3 activity was somewhat 
higher (0.1 > P > 0.05) compared to unchanged tissue 
of normofollicular structure (Table 1). An analysis of 
data depending on several clinical characteristics of tu-
mors has shown that caspase-3 activity did not depend 
on tumor size (ρ = − 0,19). At the same time, a strong 
relationship was reported between caspase-3 activity 
and those characteristics which allow to refer the tumor 
to one or another T category: with increasing category, 
caspase-3 activity was gradually decreasing (see 
Table 1). We had the possibility of studying in the pres-
ent work only one papillary carcinoma of Т1  category. 
Caspase-3 activity in tumor tissue (0.512 μmol of 
paranitroaniline/[hour х mg of protein]) exceeded by 
3.2 times the average enzyme activity in unchanged 
thyroid tissue. This difference for caspase-3 activity 
in Т2-category tumor tissue was 1.8 times (0.284 ± 
0.044 μmol of paranitroaniline/[hour х mg of protein]); 
for Т3 category tumors 1,2 times; and in Т4-category 
tumor tissue caspase-3 activity was decreased by 63% 
(see Table 1). A relationship has also been established 
between changes in caspase-3 activity and presence 
of metastases of papillary carcinoma to lymph nodes: 
the enzyme activity in the tissue of tumors without me-
tastases was higher compared to unchanged tissue, 
and somewhat higher (0.1 > P > 0.05) compared to 
metastasizing tumor tissue. Besides, caspase-3 activ-
ity was found to be much higher in the tissue of papil-
lary carcinomas of follicular-papillary structure, and 
lower in the tissue of tumors of mixed structure with 
solid areas, compared to that in the tissue of papillary 
carcinomas of typical papillary structure (see Table 1).
A subsequent analysis of the results has shown that 
caspase-3 activity differed in the tissue of carcinomas 
with a different aggressiveness of biological behaviour. 
So, in case of tumor invasion to blood vessels, enzyme 
activity was lower than in the tissue of tumors without 
invasion; in the latters caspase-3 activity was higher 
compared to unchanged thyroid tissue (Table 2). In 
the absence of tumor invasion to lymphatic vessels, 
an increased enzyme activity was noted as well. Cas-
pase-3 activity was identical in the tissue of papillary 
carcinomas with or without intrathyroid spreading of 
tumor, being, however, significantly decreased in the 
tissue of those carcinomas which spread into soft tis-
sues adjacent to the thyroid, and increased in the tis-
sue of carcinomas without that. The presence of tumor 
capsule was associated with a higher caspase-3 activ-
ity, as was the absence of fibrous-sclerotic changes in 
tumor stroma. No significant difference was noted in 
caspase-3 activity levels in tumors with oxyphilic-cell 
metaplasia or without it, as well as in tumors with a 
marked necrosis or without it (see Table 2).
Table 1. Caspase-3 activity in extratumoral unchanged thyroid tissue and 
papillary thyroid carcinoma tissue of patients
Tissue n
μmol of para-
nitroaniline/
(hour × mg of 
protein)
Р1 Р2 Р3 Р4
Unchanged tissue of 
normofollicular struc-
ture
12 0.160 ± 0.026
Papillary carcinoma 
tissue, including:
15 0.245 ± 0.037
Т1-Т2 category tumor 8 0.309 ± 0.046 <0.02
Т3 category tumor 4 0.194 ± 0.046
Т4 category tumor 3 0.059 ± 0.020 <0.01 <0.001
N0 category tumor 9 0.294 ± 0.050 <0.05
N1-N2 category tumor 6 0.171 ± 0.044
typical papillary struc-
ture of tumor
8 0.220 ± 0.032
follicular-papillary 
structure of tumor
4 0.414 ± 0.056 <0.01 <0.02
mixed structure with 
solid areas
3 0.087 ± 0.030 <0.02 <0.01
Note: Р1 — compared to the activity in extranodular unchanged thyroid tis-
sue of normofollicular structure; Р2 — compared to the activity in the tissue 
of Т1–Т2 category tumors; Р3 — compared to the activity in the tissue of tu-
mors of typical papillary structure; Р4 — compared to the activity in the tis-
sue of tumors of follicular-papillary structure.
Table 2. Caspase-3 activity in the tissue of papillary thyroid carcinomas-
depending on the characteristics of their biological behaviour
Sign under study
μmol of paranitroaniline/(hour × mg of 
protein)
Sign present Sign absent
Invasion to blood vessels 0.159 ± 0.035 (8) 0.344 ± 0.049а,b (7)
Invasion to lymphatic vessels 0.221 ± 0.054 (8) 0.273 ± 0.033а (7)
Intrathyroid spreading 0.232 ± 0.040 (11) 0.281 ± 0.087 (4)
Extrathyroid spreading 0.087 ± 0.020а (3) 0.285 ± 0.038а,b (12)
Presence of capsule 0.327 ± 0.072а (5) 0.204 ± 0.039 (10)
Oxyphilic-cell metaplasia 0.247 ± 0.049 (6) 0.244 ± 0.055 (9)
Necrotic changes 0.211 ± 0.061 (3) 0.253 ± 0.045 (12)
Fibrous-sclerotic changes in tu-
mor stroma
0.193 ± 0.047 (8) 0.305 ± 0.055а (7)
Notes: а — the difference compared to enzyme activity in unchanged tissue of 
normofollicular structure (0.160 ± 0.026 μmol of paranitroaniline / [hour х mg 
of protein]) was significant (Р < 0.05); b — the difference compared to en-
zyme activity in the tissue in the presence of a sign under study is  significant 
(Р < 0.05); in brackets — number of observations.
DISCUSSION
Today, there is no doubt as to the importance cas-
pases’ role in the biochemical mechanisms underlying 
apoptosis. In spite of the existence of some tissular 
specificity of the functioning of certain members of 
caspase family, involvement of effector caspase-3 in 
the main processes of apoptosis — both in terms of 
its initiation and cell components’ destruction — is 
recognized by most investigators [7, 15]. The fact of 
activation of this caspase, along with changes in other 
apoptosis parameters (decrease in transmembrane-
ous mitochondrial potential, asymmetric redistribu-
tion of phosphatidyl serine on plasmatic membrane, 
internucleosomic DNA fragmentation), is often used 
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as a marker of spontaneous or stimulated apoptosis 
[15–17].
We have formerly demonstrated a sharp decrease in 
caspase-3 activity in thyroid tissue in case of a marked 
hyperplasia, of microfollicular tissue structure (such 
an extratumoral tissue is often reported in the thyroid 
in case of papillary carcinoma), and in the tissue with 
signs of papillary carcinoma cell invasion — compared 
to enzyme activity in the tissue of normofollicular 
structure. Mitochondrial mechanisms of apoptosis 
initiation in cells of such tissues are also inhibited [18, 
19]. Therefore, changes in histological and follicular 
structure of extratumoral thyroid tissue, associated with 
a strong inhibition of caspase-dependent mechanisms 
of apoptosis realization, may represent one of the fac-
tors contributing to tumor spreading within the thyroid.
Such an increase in caspase-3 activity in the 
 general group of specimens of papillary thyroid 
carcinoma tissue agrees with a 3-4-fold increase in 
the number of apoptotic cells, formerly demonstrated 
in these tumors [20]. However, there is also evidence 
in the literature, of a low apoptotic activity in papillary 
thyroid carcinomas [3, 5]. The results of our studies 
suggest that changes in caspase-dependent mecha-
nisms of apoptosis in papillary carcinomas have a 
multidirectional character, which depends upon the 
stage and aggressiveness of tumoral process. At initial 
stages of tumor development, in the absence of me-
tastases to lymph nodes, tumoral cell invasion to blood 
and lymphatic vessels, extrathyroid tumor spreading, 
sclerotic and fibrous changes in tumor stroma, and 
in the presence of a capsule, caspase-3 activity was 
higher than in unchanged tissue of normofollicular 
structure. In case of a more aggressive character of 
tumor, the intensity of caspase-dependent processes 
of apoptosis in papillary carcinoma tissue was not 
significantly changed or (in case of extrathyroid tumor 
spreading) it was decreased. In combination, this was 
expressed by a gradual decrease in caspase-3 activity 
in tumor tissue with increasing T-category.
Also of interest is the presence of a difference in 
caspase-3 activity in papillary carcinomas of vari-
ous histological subtypes: in case of typical papillary 
structure of tumor, enzyme activity did not differ 
significantly from that in unchanged thyroid tissue of 
normofollicular structure, being higher in tumors of 
follicular-papillary structure and lower in tumors of 
mixed structure with presence of solid areas. Therefore, 
inhibition of caspase-dependent mechanisms of 
apoptosis was reported in cells of less well differentiated 
tumors having in their structure areas of solid structure, 
that are characterized to a considerable extent by a loss 
of orientation of epithelial cells in terms of their loca-
tion in a follicle, which may have a significant impact 
on the functional and metabolic activity of thyrocytes. 
Such carcinomas are characterized by a reduced 
potential of thyroid hormone synthesis at the expense 
of a decreased cell differentiation, and by a significant 
impairment of the process of cellular cycle blocking 
at the stage of transition to S-phase [21]. In cells of 
follicular-papillary carcinomas in which abnormalities 
in follicular tissue structure and, therefore, changes in 
epithelial cell orientation in a follicle are expressed to a 
lesser extent, while apoptotic process activity was, on 
the contrary, higher.
Thus, if we take into account that the magnitude of 
activity of caspase-3 — which is an important and the 
most universal caspase in terms of its involvement in 
apoptosis realization — is considered to be a marker 
of spontaneous apoptosis, it may be suggested that at 
initial stages of tumor growth a considerable activation 
of programmed cell death occurs in the thyroid, which 
is a response of the body to the malignant transfor-
mation of cells. With tumor growth, a decrease in the 
number of cells is observed, which formerly responded 
to apoptosis-inducing stimuli, and an increase in the 
number of cells that are unable to respond to these 
stimuli due to abnormalities in the mechanisms of ini-
tiation, regulation, and realization of apoptosis, which 
is also corroborated by the results of our previous 
investigations [19]. It should be noted that the realiza-
tion of apoptosis programme after effector caspases’ 
activation, may be blocked due to the functioning of 
proteins from the family of caspase inhibitors IAP, if the 
activity of the latters will not be inhibited by mitochon-
drial proteins-inhibitors Smac/DIABLO and Omi/HtrA2. 
It has been shown that in transformed thyroid cells the 
level of Smac/DIABLO is significantly decreased [22].
At late stages of carcinoma development, with 
an increase in tumor aggressiveness, the decrease 
in caspase-3 activity, found in our study, agrees with 
an overexpression in papillary carcinoma cells of sur-
vivine, an inhibitor of apoptosis, whose important role 
in carcinogenesis is reported just at advanced stages 
of tumor development [23], as well as XIAP, one of the 
proteins of IAP family, whose overexpression (reported 
in more than 80% of papillary thyroid carcinomas) 
correlates with an aggressive character of tumor [24].
In the literature, evidence of changes in spontaneous 
apoptosis intensity depending on the stage of tumor 
development, is contradictory. Some consider that at 
initial stages of carcinogenesis tumors are character-
ized by a low intensity of transformed cells’ death, and 
that the intensity increases along with an enhancement 
of proliferation activity at a stage of progression [25]. 
Other investigators report that in the presence of an 
increase in tumor size the intensity of spontaneous 
apoptosis is decreasing [26, 27]. Our data, obtainеd in 
the process of assessing caspase-3 activity in papillary 
thyroid carcinomas, appear to confirm the latter. They 
also agree with the fact that in cells which proliferate 
actively, a high level of free radicals is observed (that 
induce mitochondrial mechanisms of apoptosis [28], 
which, in turn, leads to caspase-3 activation); while at a 
terminal stage of tumor growth free radical concentra-
tion significantly decreases [29], and then this factor 
of apoptosis activation may not play such an important 
role. This is corroborated by the lack of response of 
papillary thyroid carcinoma cells to an excess of active 
oxygen radicals [30].
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Lung cancer is a leading cause of cancer-related 
death worldwide. That’s why numerous studies are di-
rected on estimation of etiology of this disease, search 
for tumor markers, and development of new strategies 
for lung cancer treatment. It is well recognized now that 
the etiology of lung cancer is closely related to smoking 
habits and is often associated with chronic pulmonary 
inflammation and underlying immune dysfunction. 
However, little is known yet about involvement of in-
nate immunity molecules, in particular, defensins, in 
lung tumorigenesis.
Defensins — cationic antimicrobial peptides — are 
important components of mucosal immunity which 
two major functions are thought to be direct antimi-
crobial action and modulation of innate and adaptive 
immunity in response to pathogens. According to 
accumulated evidences, expression of some alpha- 
or beta-defensins may be altered or deregulated in 
different tumor types, and these antimicrobials could 
play a complex and poorly understood role in cancer 
pathogenesis either promoting or suppressing tumor 
cell growth [1, 2].
In normalcy, defensins participate in antimicrobial 
protection of respiratory tract along with other defense 
molecules [3]. Mailfunction or altered expression of 
these peptide antibiotics has been well documented 
in a number of chronic lung pathologies, in particular, 
cystic fibrosis, reactive airway disease, tuberculosis and 
many other lung infections [4]. There are some data evi-
dencing on reduced levels of beta-defensin-2 (hBD-2) 
in sputum and pharyngeal washes of smokers versus 
nonsmokers with acute pneumonia [5] what points on 
possible smoking-dependent down-regulation of this 
peptide in airway epithelium. At the same time, up-to-
date there are scarce data for defensin expression pat-
terns in lung cancer. In our recent pilot study [6] we have 
recorded an altered expression of hBD-1-4 mRNAs in 
lung cancer samples versus normal lung tissue.
In this regard we aimed to analyze further the 
expression patterns of hBD-2 in human lung tumor 
samples using immunohistochemical approach.
MATERIALS AND METHODS
In the study, 31 samples of surgically resected 
human lung tumors of different histological type were 
studied. The tissue samples were obtained during the 
surgical treatment of lung cancer patients cured in 
the Thoracic Department of National Cancer Institute 
(Kyiv, Ukraine) in 2001–2008 (Head of the Dept., prof. 
V.L.Ganul). Immediately after surgical removal, tissue 
samples were placed in liquid nitrogen and stored at 
-70 oC until use. The patients did not receive chemo- or 
radiotherapy prior to the surgery. All patients provided 
an informed written consent to perform the study, and 
the present research was approved by Ethic Board of 
the Institute. Histological type and differentiation grade 
of lung tumors has been estimated by clinical patholo-
gists (National Cancer Institute, Dept. Pathol. Anat. Dr. 
E.N. Kovalchuk and Dr. I.N. Troitskaya). From 31 lung 
tumor samples, 1 tumor was diagnosed as small-cell 
lung cancer (SCLC), and 30 — as non-small cell lung 
cancer (NSCLC). The last group of tumors included 
1 case of clear cell large cell lung cancer, 9 cases of 
squamous cell carcinoma (SCC), and 20 cases of ad-
enocarcinoma (AC). The clinico-pathological charac-
teristics of lung cancer cases are presented in Table 1.
Immunohistochemical analysis. Tumor tissue 
samples were fixed in 4% formaldehyde for 24 h at 
room temperature, then dehydrated in 50%, 70%, 80%, 
90%, 96% spirits, treated with chloroform, saturated 
with paraffin at 56 оС for 30 min and placed in paraffin 
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